MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Absence of the nigrosome-1 area in 3 tesla resonance and its relation with hyperechogenicity of the substantia nigra in patients with Parkinson’s disease

    J.S. Bestoso, M. Pérez Akly, L. Ciancaglini, C. Stefani C, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)

    Objective: To compare the usefulness of two neuroimaging methods (3TMR and MEcho) to assist in the diagnosis of PD. Background: In patients with Parkinson's disease…
  • 2018 International Congress

    Cholinergic basal forebrain and hippocampal structure influence visuospatial function in Parkinson’s disease

    R. Berlot, S. Brezovar, B. Koritnik, Z. Pirtošek, N. Ray (Ljubljana, Slovenia)

    Objective: To assess relationships between the structural status of the cholinergic basal forebrain (cBF), hippocampus (HPC) and multi-domain cognitive function in Parkinson’s disease (PD). Background:…
  • 2018 International Congress

    Anti-glutamatergic effect of safinamide in Parkinson’s Disease: A TMS study

    A. Guerra, A. Suppa, V. D'Onofrio, F. Di Stasio, F. Asci, G. Fabbrini, A. Berardelli (Rome, Italy)

    Objective: To test the effect of safinamide, at the doses of 50 and 100 mg/day, on primary motor cortex (M1) excitability and glutamatergic neurotransmission in…
  • 2018 International Congress

    The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease

    Z. Mao, Z. Xue (Hubei, China)

    Objective: In this study,we were to investigate imaging characteristics of 18F-FDG PET/CT in patients with Parkinson's disease (PD), and explore its value on PD. Background:…
  • 2018 International Congress

    Pallidal beta bursts in Parkinson’s disease and Dystonia

    R. Lofredi, WJ. Neumann, C. Brücke, J. Huebl, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: The aim of this study is to test whether prolonged beta burst duration is disease-specific for Parkinson's disease when compared to oscillatory activity in…
  • 2018 International Congress

    Subthalamic Nucleus Local Field Potential Beta Activity in Chinese Advanced PD Patients

    J. Wu, J. Li, C. Xu, S. Mei, Y. Zhang (Minneapolis, MN, USA)

    Objective: To test if the β oscillations of subthalamic nucleus (STN) local field potential (LFP) in Chinese advanced Parkinson’s disease (PD) patients are similar with…
  • 2018 International Congress

    A Florbetapir [F18] amyloid PET Imaging study in Parkinson’s disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression

    G. Palermo, G. Aghakhanyan, L. Tommasini, D. Frosini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: To determine whether amyloid deposition, as assessed by PET imaging with the [18F]-Florbetapir, is related in patients with Parkinson Disease and Dementia (PDD) to…
  • 2018 International Congress

    Diffusion tensor imaging of olfactory tract in Parkinson’s disease

    P. Nigro, N. Tambasco, A. Chiappiniello, S. Simoni, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: We investigated the possible relationships among olfactory impairment and alterations in diffusion tensor imaging (DTI) of olfactory tracts, comparing a cohort of patients with…
  • 2018 International Congress

    Gender Differences in Parkinson’s disease: Transcranial Magnetics Stimulation Study of Newly Diagnosed Drug-Naïve PD Patients

    K. Kolmancic, R. Alfonso, Z. Pirtosek, K. Bhatia, M. Kojovic (Ljubljana, Slovenia)

    Objective: In early Parkinson’s disease (PD), functional changes may be detected in primary motor cortex (M1) using transcranial magnetic stimulation (TMS). We hypothesised that, if…
  • 2018 International Congress

    Neuroprotective effect of exogenous melatonin on apoptosis of neuroadernergic neurons in a rat model of Parkinson’s disease

    F. Yadolahi, M. Mehrpour (Tehran, Islamic Republic of Iran)

    Objective: To investigate melatonin therapeutic potential effects in Parkinson’s disease. Background: Sleep disorders constitute major nonmotor features of Parkinson’s disease (PD) that have a substantial…
  • « Previous Page
  • 1
  • …
  • 1548
  • 1549
  • 1550
  • 1551
  • 1552
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley